During the pandemics like COVID-19, a novel approach is required to accelerate research and access to treatment. National COVID Cohort Collaborative (N3C) is one such initiative which aims to build a centralized national data resource for research community to study COVID-19 and identify potential treatment options. N3C will enable the rapid collection and analysis of clinical, laboratory and diagnostic data from hospitals and health care plans.

In this podcast, Melissa Haendel, Director at CD2H and Christopher Chute Co-Director at CD2H discuss the key goals of the N3C initiative and its unique value proposition. The podcast provides insights into how this collaborative effort brings together experts with knowledge, skills, and experience to address this urgent public health issue. The podcast outlines the scope, opportunities, and challenges of N3C association with the commercial groups such as pharma & med-devices. It also touches upon the various roadblocks faced by the team in their journey so far.

Advanced real-world data including clinical notes, imaging, consumer data, and remote monitoring are redefining therapeutic value in modern reimbursement and prescribing dialogs. In the latest episode of Graticule’s Novel Cohorts Podcast Ömer Saka, Real-World Evidence Leader at PwC Switzerland and Dan Housman, CTO & Co- founder at Graticule, Inc. explore the emergence of a new generation of therapeutic value research.

In this episode of Graticule’s Novel Cohorts podcast, Dan Housman speaks with Eamonn Costello from patientMpower on how remote monitoring is growing to support Real World Data studies, clinical research, and COVID-19.

Dan Housman, CTO, Graticule and Jeff Wessinger, Consultant, PointClickCare discuss Real World Data Capabilities for Covid-19